Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Herdis Steingrimsdottir is active.

Publication


Featured researches published by Herdis Steingrimsdottir.


American Journal of Human Genetics | 1998

Molecular Analysis of Mutations in the CSB(ERCC6) Gene in Patients with Cockayne Syndrome

Donna Mallery; Bianca Tanganelli; Stefano Colella; Herdis Steingrimsdottir; Alain J. van Gool; Christine Troelstra; Miria Stefanini; Alan R. Lehmann

Cockayne syndrome is a multisystem sun-sensitive genetic disorder associated with a specific defect in the ability to perform transcription-coupled repair of active genes after UV irradiation. Two complementation groups (CS-A and CS-B) have been identified, and 80% of patients have been assigned to the CS-B complementation group. We have analyzed the sites of the mutations in the CSB gene in 16 patients, to determine the spectrum of mutations in this gene and to see whether the nature of the mutation correlates with the type and severity of the clinical symptoms. In nine of the patients, the mutations resulted in truncated products in both alleles, whereas, in the other seven, at least one allele contained a single amino acid change. The latter mutations were confined to the C-terminal two-thirds of the protein and were shown to be inactivating by their failure to restore UV-irradiation resistance to hamster UV61 cells, which are known to be defective in the CSB gene. Neither the site nor the nature of the mutation correlated with the severity of the clinical features. Severe truncations were found in different patients with either classical or early-onset forms of the disease.


Mutation Research-dna Repair | 1993

Molecular analysis of mutations in the hprt gene in circulating lymphocytes from normal and DNA-repair-deficient donors

Herdis Steingrimsdottir; G. Rowley; Alastair P.W. Waugh; David M. Beare; I. Ceccherini; Jane Cole; Alan R. Lehmann

Circulating lymphocytes from patients with the DNA-repair-deficient disorders, xeroderma pigmentosum (XP) and ataxia telangiectasia (A-T) have elevated frequencies of mutants at the hypoxanthine-guanine phosphoribosyltransferase (hprt) locus. We have analysed the DNA sequence of the hprt gene in mutants from normal donors, and compared them with mutants from XP and A-T individuals. In normal donors we found a range of mutations including principally transitions (40%), transversions (32%) and small deletions (20%). In an excision-deficient XP donor from complementation group C the mutation spectrum was similar to that from normal donors, whereas in an XP variant there was a significantly higher frequency (44%) of small deletions. In the two A-T donors, there was a high frequency of large deletions (22 and 75%) compared with only 4% in normal donors.


Journal of Molecular Biology | 1991

Molecular analysis of ultraviolet-induced mutations in a xeroderma pigmentosum cell line

G. Dorado; Herdis Steingrimsdottir; C.F. Arlett; Alan R. Lehmann

We have isolated and characterized 47 ultraviolet light-induced hprt mutants from a simian virus 40-transformed excision-repair-deficient xeroderma pigmentosum cell line (complementation group A). Twenty-one independent mutations were found, of which the majority were point mutations. Eleven of these were identified as base changes, nine of which could be attributed to ultraviolet damage on the transcribed DNA strand. Both transitions and transversions were found among the single base changes. A large proportion of the mutations (13/21) resulted in aberrant splicing of the hprt gene, suggesting that the target size for mutations resulting in aberrant splicing must be quite large. A small number of spontaneous mutations were identified, most of which were large deletions. Our data provide a spectrum for the intrinsic mutations resulting from ultraviolet damage in human cells in the absence of repair.


Gene | 1988

SV40-transformed normal and DNA-repair-deficient human fibroblasts can be transfected with high frequency but retain only limited amounts of integrated DNA

Lynne V. Mayne; Tina Jones; Stephen W. Dean; Susan A. Harcourt; Jill E. Lowe; Anne Priestley; Herdis Steingrimsdottir; Hazel R. Sykes; M.H.L. Green; Alan R. Lehmann

The ability of simian virus 40-transformed human fibroblasts to integrate and maintain transfected genomic DNA has been investigated in two normal and six DNA-repair-deficient human cell lines. These cell lines were transfected with DNA containing two selective markers (G418 and hygromycin (Hyg) resistance) separated by random pieces of human DNA of 0-40 kb in length. The transfection frequency for the selected (G418R) marker was between 2 x 10(-4) and 2 x 10(-3) for all cell lines, comparable to many other mammalian systems. About 50% of the G418R colonies were also initially resistant to Hyg. Analysis of the DNA from individual clones expanded for a further month revealed, however, that about one to three copies of the selected marker but only about 0.1 copy per cell of the unselected marker were maintained. Our results were broadly similar for all eight cell lines. Thus the amount of integrated DNA that is stably maintained in these cells is in general very small (less than 50 kb). This may provide an explanation for the difficulties encountered in many laboratories in attempts to correct the defect in DNA-repair-deficient human cells by transfection with genomic DNA. Our results also show that none of several defects in DNA repair has any obvious effect on either the transfection frequency or the amount of stably integrated foreign DNA.


Environmental and Molecular Mutagenesis | 1997

Correlated mutagenesis of bcl2 and hprt loci in blood lymphocytes

Yafei Liu; Gino Cortopassi; Herdis Steingrimsdottir; Alastair P.W. Waugh; David M. Beare; M.H.L. Green; Derek R. Robinson; Jane Cole

In vivo measurement of human somatic mutations may be a valuable biodosimeter of exposure to carcinogens and of cancer risk. We have surveyed translocations of the bcl2 locus in B lymphocytes, and mutations of hprt in T lymphocytes, in 120 individuals with varying exposure to radon and cigarette smoke. bcl2 t(14: 18) translocation is the commonest chromosomal alteration observed in non‐Hodgkins lymphoma (NHL). We observed a significantly larger range of bcl2 translocation frequency (range: 0–372 × 10−6, median: 1.9 × 10−6) than of hprt mutation frequency (range: 0–76.4 × 10−6, median: 11.1 × 10−6), which is likely the result of clonal proliferation of deathless B cell mutants. We observed that the frequencies of these two distinct lymphocytic mutations are significantly correlated. Although some of the correlated variation is explained by age, a significant correlation of bcl2 mutagenesis persists after age adjustment. Correlated mutagenesis at distinct loci in distinct cell types could be explained by the existence of a mutator phenotype or by variation in exposure to environmental mutagens. NHL is commoner in men than in women, and our data indicate a trend toward higher bcl2 mutagenesis in males than females. There is mounting epidemiological evidence for a worldwide increase in NHL, which may have an environmental basis; molecular epidemiological analysis of bcl2 mutagenesis in exposed populations might be especially relevant to the identification of putative environmental causes. Given the relative ease of the bcl2 assay versus the hprt assay, and the consistency with which data are reproduced from laboratory to laboratory, it is likely that the bcl2 assay will be soon added to the array of assays used in human mutational surveillance. Environ. Mol. Mutagen. 29:36–45, 1997


Mutation Research | 1996

Development of new molecular procedures for the detection of genetic alterations in man

Herdis Steingrimsdottir; D Beare; Jane Cole; J.F.M Leal; T Kostic; J Lopez-Barea; G Dorado; Alan R. Lehmann

The Restriction Site Mutation (RSM) procedure is a DNA-based method for detecting mutations at any unselected locus. Mutations are identified as alterations of the DNA sequence at a chosen restriction site. DNA from cells exposed to mutagenic treatment is exhaustively digested with the restriction enzyme (RE). Sequences containing the mutated target site are specifically amplified using the polymerase chain reaction (PCR), whereas DNA without mutations at this site will have been cleaved and can not therefore provide a substrate for PCR. We have developed this procedure using both bacterial and mammalian cells. With bacteria, in plasmid reconstruction experiments we were able to detect mutations at a frequency of 10(-6) at an EcoRI site in the AraA locus of Salmonella typhimurium. The detection limit with an RsaI site in the lacI gene of Escherichia coli was 10(-5), and we were able to detect DNA damage and repair after treatment with N-methyl-N-nitrosourea (MNU). With mammalian cells, we have detected mutations induced by ethyl methanesulphonate (EMS) at a TaqI site in the aprt gene of Chinese hamster cells. In extensive studies with normal and repair-deficient human cells, we have detected and sequenced mutations induced by UV-C or UV-B in fibroblasts and lymphoblastoid cells from repair-deficient xeroderma pigmentosum (XP) donors. Similar results were obtained at TaqI sites in three genes, hprt, c-Ha-rasI and p53. These results demonstrate that the system is able to detect and analyse mutations induced at high frequencies. In our extensive attempts to extend the work to conditions of lower mutation frequencies, we have encountered several obstacles, the most serious being false-positive mutant DNA in totally untreated cells. This appeared to be a cell-line specific phenomenon, which we have not been able to eliminate by altering conditions. We propose therefore that, at present, RSM is a suitable method for studying high mutation frequencies at different loci and could be used for mutagen testing with repair-deficient cells. As yet, however, its sensitivity and specificity is not sufficient for population monitoring.


Mutation Research\/reviews in Genetic Toxicology | 1989

Mutagenic treatments result in inactivation of expression of a transfected bacterial gene integrated into a human cell line.

Alan R. Lehmann; C.F. Arlett; Susan A. Harcourt; Herdis Steingrimsdottir; M.M. Gebara

The cell line E2 is a SV40-transformed human fibroblast cell line containing a single integrated copy of the bacterial guanine phosphoribosyl transferase (gpt) gene. Treatment of E2 with ultraviolet light (UV) or ethyl methanesulphonate (EMS) induced the formation of Gpt- derivatives. Several induced derivatives have been isolated, and the structure, expression and revertibility of the gpt gene have been analysed. In the majority of cases the Gpt- phenotype resulted from switching off the gpt gene, in most instances by methylation, but in a few cases by phenotypic switching. Thus mutagenic treatment can result in the inactivation of gene expression in human cells. In a small proportion of Gpt- derivatives the gpt sequences were deleted.


New Trends in Genetic Risk Assessment | 1989

4 – Molecular Analysis of Genetic and Epigenetic Alterations in Human Cells

Alan R. Lehmann; C.F. Arlett; M.M. Gebara; Susan A. Harcourt; M.R. James; J.R. Lamb; W.J. Muriel; Herdis Steingrimsdottir

Publisher Summary Recombinant DNA technology and DNA sequencing techniques allow mutations induced in mammalian cells to be analyzed at the molecular level. If the gene in which mutations are induced has been cloned, gross structural alterations are readily detected by Southern analysis. Point mutations or small deletions are much more difficult to analyze. Several different mutation systems have been subjected to molecular analysis. Mutations in endogenous genes are analysed by the cloning and sequencing of the entire mutated gene from the mammalian genome. Endogenous genes are the ideal system to use. Mutations in mammalian viral genes are analyzed by the recovery of the mutated viral particles and the sequencing of their DNA. Shuttle vectors are designed in which a target gene is inserted into a plasmid that is capable of replicating both in bacterial and mammalian cells. The plasmid is mutated inside the mammalian cell, after which it is recovered from the mammalian cell and used to transform suitable indicator bacteria in which mutations induced in the target gene inside the mammalian cell is easily identified and analysed in the bacteria.


Nature Genetics | 1994

Mutations in the xeroderma pigmentosum group D DNA repair/transcription gene in patients with trichothiodystrophy

Bernard C. Broughton; Herdis Steingrimsdottir; Christine A. Weber; Alan R. Lehmann


Cancer Research | 1988

Trichothiodystrophy, a Human DNA Repair Disorder with Heterogeneity in the Cellular Response to Ultraviolet Light

Alan R. Lehmann; C.F. Arlett; Bernard C. Broughton; Susan A. Harcourt; Herdis Steingrimsdottir; Miria Stefanini; A. Malcolm R. Taylor; A.T. Natarajan; Stuart A. Green; Mary D. King; Rona M. MacKie; John B.P. Stephenson; John Tolmie

Collaboration


Dive into the Herdis Steingrimsdottir's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge